Mirum Pharmaceuticals Stock Price on November 12, 2024
| MIRM Stock | USD 46.22 0.43 0.92% |
Below is the normalized historical share price chart for Mirum Pharmaceuticals extending back to July 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mirum Pharmaceuticals stands at 46.22, as last reported on the 29th of November, with the highest price reaching 47.08 and the lowest price hitting 46.09 during the day.
If you're considering investing in Mirum Stock, it is important to understand the factors that can impact its price. Mirum Pharmaceuticals appears to be very steady, given 3 months investment horizon. Mirum Pharmaceuticals has Sharpe Ratio of 0.0937, which conveys that the firm had a 0.0937% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Mirum Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Mirum Pharmaceuticals' Mean Deviation of 1.79, downside deviation of 2.51, and Risk Adjusted Performance of 0.0412 to check out if our risk estimates are consistent with your expectations.
At this time, Mirum Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 679 M, while Common Stock Shares Outstanding is likely to drop about 32.3 M. . At this time, Mirum Pharmaceuticals' Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price Earnings To Growth Ratio is likely to grow to 31.10, while Price Earnings Ratio is likely to drop (7.75). Mirum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2019 | 200 Day MA 33.9139 | 50 Day MA 40.6422 | Beta 1.162 |
Mirum |
Sharpe Ratio = 0.0937
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MIRM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.35 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Mirum Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mirum Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 9.6516 | Enterprise Value Ebitda (8.85) | Price Sales 7.2938 | Shares Float 36.2 M | Wall Street Target Price 62.5455 |
Mirum Pharmaceuticals Main Headline on 12th of November 2024
Mirum Pharmaceuticals delivered earnings and revenue surprises of 33.33 percent and 9.77, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Mirum Pharmaceuticals Valuation on November 12, 2024
It is possible to determine the worth of Mirum Pharmaceuticals on a given historical date. On November 12, 2024 Mirum was worth 44.0 at the beginning of the trading date compared to the closed value of 42.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mirum Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Mirum Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mirum Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mirum Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 42.25 | 42.49 | 41.46 | 41.61 | 287,869 | |
11/12/2024 | 44.00 | 45.81 | 41.09 | 42.28 | 717,971 |
| 43.15 | 44.64 | 42.48 | 43.92 | 622,288 |
| Backtest Mirum Pharmaceuticals | | | Mirum Pharmaceuticals History | | | Mirum Pharmaceuticals Valuation | Previous | Next |
Mirum Pharmaceuticals Trading Date Momentum on November 12, 2024
| On November 13 2024 Mirum Pharmaceuticals was traded for 43.92 at the closing time. The top price for the day was 44.64 and the lowest listed price was 42.48 . The trading volume for the day was 622.3 K. The trading history from November 13, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 3.88% . The trading delta at closing time against the current closing price is 2.79% . |
Mirum Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Mirum Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mirum Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mirum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mirum Pharmaceuticals Stock history
Mirum Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mirum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mirum Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mirum Pharmaceuticals stock prices may prove useful in developing a viable investing in Mirum Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 40.9 M | 32.3 M | |
| Net Loss | -122.1 M | -128.2 M |
Mirum Pharmaceuticals Quarterly Net Working Capital |
|
Mirum Pharmaceuticals Stock Technical Analysis
Mirum Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mirum Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Mirum Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mirum Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Mirum Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mirum Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Mirum Pharmaceuticals stock market strength indicators, traders can identify Mirum Pharmaceuticals entry and exit signals to maximize returns
Mirum Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mirum Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Mirum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mirum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0412 | |||
| Jensen Alpha | 0.016 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1374 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 6.513 | Quarterly Revenue Growth 0.894 | Return On Assets (0.09) | Return On Equity (0.40) |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.